Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE FDNA Inc.
NEW YORK, June 30, 2014 /PRNewswire/ --
FDNA® (http://www.fdna.com) - a pioneer in computer-aided dysmorphology analysis is proud to announce that four of Europe's leading thought leaders in genetics and human dysmorphology have been appointed to the steering committee of its Scientific Advisory Board (SAB). These appointments further strengthen the SABs strategic role in assisting FDNA on its mission to save lives and improve the quality of life of patients with rare or difficult-to-diagnose genetic syndromes.
"Our SAB plays a pivotal role in shaping our vision and offering for next generation computer-aided dysmorphology analysis. The addition of these leading experts to our scientific advisory board further underscores our commitment to continue offering our Facial Dysmorphology Novel Analysis (FDNA) technology free to the genetics expert community." said Dekel Gelbman, CEO of FDNA Inc. "With the support of our SAB and in line with our community commitment, we are offering Face2Gene™, our free mobile search and reference application, designed to accelerate and increase confidence in dysmorphology evaluations".
Leading Genetics Experts added to FDNA's SAB:
Prof. Dian Donnai, CBE, FMedSci, FRCP
Prof. Donnai is Professor of Medical Genetics at the University of Manchester and Clinical Head of Saint Mary's Division/Consultant Manchester Centre for Genomic Medicine at Central Manchester University Hospitals NHS Foundation Trust.
Prof. Arnold Munnich, MD, PhD
Prof. Munnich is Director of the Department of Genetics at Hospital Necker, University Paris-Descartes. He is the Director of an INSERM Research Laboratory. Prof. Munnich is on the editorial board of the Journal of Medical Genetics, European Journal of Human Genetics, Human Genetics, Clinical Genetics and Human Molecular Genetics. He served as advisor to the former President of the French Republic, Nicolas Sarkozy.
Prof. Jill Clayton-Smith, MD, MB ChB, MRCP, FRCP
Prof. Clayton-Smith is Consultant Clinical Geneticist at North Western Regional Genetic Service, Honorary Professor in Medical Genetics and Clinical Lead for Research at Saint Mary's Division/Consultant Manchester Centre for Genomic Medicine at Central Manchester University Hospitals NHS Foundation Trust. Prof. Clayton-Smith
Dr. Sofia Douzgou, MD
Dr. Douzgou is a consultant at the Manchester Centre for Genomic Medicine at Central Manchester University Hospitals NHS Foundation Trust. She is co-organizer of the International Manchester Dysmorphology Course and Conference and has assisted the Orphanet.
"It is a pleasure for me, as the chairman of FDNA's scientific advisory board, to welcome these distinguished European genetics experts as members of the steering committee." said Dr. Michael R. Hayden, CM, OBC, FRSC, Chairman of FDNA's Scientific Advisory Board & Steering Committee. "I look forward to working with the new members in advising FDNA's management in providing new and valuable tools for the new era of clinical dysmorphology."
FDNA's mission is to save lives and improve the quality of life of patients with rare or difficult-to-diagnose genetic syndromes. FDNA® has developed the proprietary Facial Dysmorphology Novel Analysis technology. This cutting-edge technology facilitates comprehensive analyses of dysmorphic features and recognizable patterns of human malformations from facial photos. Using advanced learning algorithms, the technology improves over time, referencing comprehensive phenotype databases in real-time.
Using the power of cloud-computing and a HIPAA compliant community platform, FDNA brings this innovation to mobile devices. FDNA's solutions aid and empower in accelerating and increasing confidence in the research and investigation of genetic syndromes while leveraging the ever-increasing amounts of data in human genetics and dysmorphology.
Face2Gene is a search and reference tool provided for informational purposes and not intended to replace clinician's judgment or experience, nor should it be used to diagnose or treat medical conditions.
©2012 PR Newswire. All Rights Reserved.